Schrodinger

SDGR · NASDAQ

$23.40+$0.28 (+1.21%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $23.12

About SDGR

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 850 full-time employees. The company went IPO on 2020-02-06. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The firm's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.

Employees: 850
Headquarters: New York City, New York
Listed: Feb 6, 2020
Sector: Health Care
Industry: Health Care Technology
Website: schrodinger.com

Leadership

Schrodinger executives
Name	Title	Since	Age
Michael Lynton	—	—	65
Ramy Farid	—	2008	60
Richie Jain	—	—	—
Karen Akinsanya	—	—	57
Yvonne Tran	—	—	54
Robert Abel	—	—	43
Mannix Aklian	—	—	—
Kenneth Lorton	—	—	41
Margaret Dugan	—	—	68
Richard Friesner	—	—	72
Jeffrey Chodakewitz	—	—	69
Gary Ginsberg	—	—	62
Rosana Kapeller-Libermann	—	—	61
Arun Oberoi	—	—	70
Gary Sender	—	—	63
Nancy Thornberry	—	—	68
Bridget Van Kralingen	—	—	62

Revenue by product and region

Fiscal year ended Dec 31, 2025: $255.87M total revenue

By region

United States$152.96M59.8%
EMEA$75.16M29.4%
APAC$26.18M10.2%
Rest of World$1.56M0.6%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Schrodinger suppliers and customers
Company	Relationship	Country	Correlation
Zai Lab	Supplier and customer	CN	0.96
Centessa Sp ADS CNTA	Supplier and customer	GB	0.95
Viva Biotech	Supplier and customer	CN	0.94
Morphic Holding MORF	Supplier and customer	US	0.87
Credit Suisse Group CSGN.SW	Supplier and customer	CH	0.71
Takeda Pharmaceutical	Supplier and customer	JP	0.37
Sun Pharma Advanced Rsch	Supplier and customer	IN	-0.26
Alphabet A GOOGL	Supplier	US	-0.29
NVIDIA NVDA	Supplier	US	-0.30
Bristol-Myers Squibb BMY	Supplier and customer	US	-0.31

Similar companies

Companies in the same industry as Schrodinger

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.